Emergency surgery for bleeding brain blood vessel malformation
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This study tests emergency surgery for patients with bleeding from a brain blood vessel malformation (AVM). It aims to see if urgent surgery can help people with this type of stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have bleeding in the brain confirmed by a CT scan and need emergency surgery.
- A CT angiogram (CTA) suggests a blood vessel malformation (AVM) is the cause.
- Your AVM is of a certain size and location (scored as grades 1 to 4 out of 6).
- You are between 18 and 70 years old and healthy enough for surgery.
- You agree to the surgery and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects medical and imaging information from people with a brain arteriovenous malformation (AVM) to understand how different treatments are used in real life. It may help doctors improve future care, even if you are not receiving a new drug in this study.
This study looks at how brain arteriovenous malformations (abnormal connections between arteries and veins in the brain) behave over time, and how different treatment choices affect outcomes. It may help researchers better predict prognosis and guide future care.
This study is looking at treatment options for people who have an abnormal cluster of blood vessels in the brain (an AVM). It may help participants by offering a structured treatment approach, depending on the AVM type and recent symptoms.
This trial tests a type of keyhole surgery called neuroendoscopic surgery to remove large blood clots in the brain. It may help people who have had a serious brain bleed and need urgent surgery.
This study looks at people who have both a brain arteriovenous malformation (tangled abnormal blood vessels) and an aneurysm in the same area. The goal is to better understand how these conditions act together and what happens over time. You will not receive any new treatment, but your medical information and follow-up will help doctors learn more.
This trial tests a liquid embolic agent (a gel-like material) injected into the blood vessels of a brain arteriovenous malformation (AVM) to block abnormal blood flow. It’s for people aged 18 to 80 with certain types of AVMs that doctors think can be treated this way.
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.